EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Matrix stiffness shapes transcriptional profiles and drug responses of pancreatic cancer cells

Eleonora Peerani, Juliana B Candido, Eleni Maniati, Elena Tomás-Bort, Shreya Sharma, Julien Clegg, Hemant M Kocher, Jun Wang, Rodrigo Curvello, Daniela Loessner

Acta Biomaterialia · 2026-01 · 210 · 67-81

DOI: 10.1016/j.actbio.2025.12.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-01. Verfasst von Eleonora Peerani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Extracellular Matrix, Transcriptome, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Wellcome Trust, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer tissues are made of different cell populations surrounded by a dense extracellular matrix. The stiff cancerous matrix impairs the diffusion of cytotoxic drugs, contributing to poor outcomes for patients. Matrix-targeting therapies normalise the extracellular matrix and, therefore, cell-matrix interactions. However, our knowledge of how matrix stiffness influences cancer cell and transcriptional dynamics and responses to anti-cancer compounds is incomplete. Here we developed a 3D cancer model to replicate the stiffness of patient-derived tissues and evaluated the effects of matrix-targeting compounds. Transcriptomic analyses showed that matrix stiffness regulated matrisome-related genes, cytokines and chemokines. The inclusion of stromal cells further increased the mechanical properties of our 3D cancer model. Treatment with the ROCK inhibitor fasudil induced matrix softening and improved sensitivity of cancer and stromal cells to cytotoxic treatment, whereas inhibition of matrix metalloproteinases disrupted cancer cell invasion. Our results indicate that matrix stiffness impacts cancer cell profiles, and targeting the cancerous matrix may lead to improved combination therapies for pancreatic cancer. STATEMENT OF SIGNIFICANCE: Pancreatic cancers have a dense extracellular matrix that drives resistance to therapy and disease progression, yet the mechanistic links between matrix stiffness and cancer cell behaviour are unclear. We engineered a 3D cancer model based on mechanical profiling of patient tissues to investigate how matrix stiffness influences gene expression and drug response. We found that increased stiffness regulates matrisome and inflammatory genes, and that stromal-induced stiffening affects sensitivity to matrix-targeting and cytotoxic drugs. The inhibition of Rho-kinase signalling enhanced the efficacy of cytotoxic drugs. These findings establish matrix stiffness as a key factor in tumour biology and therapy response, supporting the use of our preclinical model to guide new combination treatments for pancreatic cancer, aimed at improving outcomes for patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsExtracellular MatrixTranscriptomeGene Expression Regulation, NeoplasticAntineoplastic AgentsHumansCell Line, Tumor1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineGene Expression Profiling

Stichwörter der Autor:innen

3D modelExtracellular matrixPancreatic cancerStiffnessTranscriptomics

Substanzen

Antineoplastic Agents1-(5-Isoquinolinesulfonyl)-2-Methylpiperazinefasudil

Autor:innen und Institutionen

  • Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, EC1M 6B…
  • Department of Chemical and Biological Engineering, Faculty of Engineering, Monash University, Clayton, Australia.
  • Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ London, United Kingdom.
  • Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ London, United Kingdom.
  • Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom; Department of Chemical and Biological Engineering, Faculty of Engineering, Monash University,…

Förderung

  • European Research Council
  • Wellcome Trust
  • Cancer Research UK
  • Horizon 2020 Framework Programme
  • H2020 European Research Council

Zitieren

APA

Peerani, E., Candido, J. B., Maniati, E., Tomás-Bort, E., Sharma, S., Clegg, J., Kocher, H. M., Wang, J., Curvello, R., & Loessner, D. (2026). Matrix stiffness shapes transcriptional profiles and drug responses of pancreatic cancer cells. Acta Biomaterialia, 210, 67-81. https://doi.org/10.1016/j.actbio.2025.12.020

Vancouver

Peerani E, Candido JB, Maniati E, Tomás-Bort E, Sharma S, Clegg J, et al. Matrix stiffness shapes transcriptional profiles and drug responses of pancreatic cancer cells. Acta Biomaterialia. 2026;210:67-81. doi:10.1016/j.actbio.2025.12.020

BibTeX
@article{Peerani2026,
  author = {Peerani, Eleonora and Candido, Juliana B and Maniati, Eleni and Tomás-Bort, Elena and Sharma, Shreya and Clegg, Julien and Kocher, Hemant M and Wang, Jun and Curvello, Rodrigo and Loessner, Daniela},
  title = {Matrix stiffness shapes transcriptional profiles and drug responses of pancreatic cancer cells},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {210},
  pages = {67--81},
  doi = {10.1016/j.actbio.2025.12.020}
}
Kostenlos starten →